from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3493c/-

LFCtreatmentdescriptionclass of inhibitor

-0.410

Amikacinug/mL Amikacintranslation

-0.705

Cap5-10ug/mL Capreomycintranslation

-1.579

Rox10-50 ug/mL Roxithromycintranslation

-0.183

SM2-5 ug/mL Streptomycintranslation

-1.151

Tet5-10 ug/mL Tetracyclinetranslation

0.011

Rif0.2-5ug/mL Rifampicintranscription

0.811

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.304

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.840

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.142

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.204

Clofazimine10-13 ug/mL Clofaziminerespiration

0.772

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.550

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.513

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.278

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.746

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.892

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.186

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.859

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.546

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.655

KCN5-20 ug/mL Potassium cyaniderespiration

0.363

NaN30.2-2 mM Sodium aziderespiration

0.384

Nigericin50 uM Nigericinrespiration

0.068

TRC10-150 ug/mL Triclosanrespiration

-1.379

TRZ10-25 ug/mL Thioridazinerespiration

-2.016

Valinomycin0.5-10 uM Valinomycinrespiration

0.710

ZnSO42 mM ZnSO4respiration

-1.779

menadione6-10 ug/mL Menadionerespiration

-0.079

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.637

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.175

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.812

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.522

NRP_1Non-replicating persistence stage 1dosRassociated

0.742

Amp0.2mg/mL AmpicillincellWall

0.253

Cephalexin20-100 ug/mL CephalexincellWall

-0.280

Cerulenin0.32-5 ug/mL CerulenincellWall

0.533

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.315

EMB10-20 ug/mL EthambutolcellWall

0.428

Eta12-40 ug/mL EthionamidecellWall

0.154

INH0.2-0.4 ug/mL IsoniazidcellWall

0.234

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.744

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.856

BZA0.12 mg/mL BenzamidearomaticAmides

0.303

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.085

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.183

H2O24 mM hydrogen peroxideDNAdamaging

-0.009

Levo10 ug/mL LevofloxacinDNAdamaging

-0.021

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.633

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.071

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.423

UVUV-irradiationDNAdamaging

-0.383

ARP41-4 ug/mL Antitubercular compound ARP4?

0.313

Antimycin12.5-50 ug/mL Antimycin A?

0.593

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.444

PA_110-50 ug/mL Antitubercular compound PA-1?

0.406

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.913

PA8240.2-2 ug/mL PA-824?

-1.526

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.086

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.566

Verapamil50 uM Verapamil?

0.454

mercaptoethanol2 mM 2-Mercaptoethanol?

0.937

methoxatin10-20 ug/mL Methoxatin?